Hitech Bio Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 K
as on 25-10-2024
- Paid Up Capital ₹ 10.00 K
as on 25-10-2024
- Company Age 1 Year 11 Months
- Last Filing with ROC 31 Mar 2023
About Hitech Bio Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 K and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Neeraj Tiwari and Neelam Tiwari serve as directors at the Company.
- CIN/LLPIN
U24290GJ2023PTC138218
- Company No.
138218
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2023
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hitech Bio Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Tiwari  | Director | 06-Jan-2023 | Current |
| Neelam Tiwari | Director | 06-Jan-2023 | Current |
Financial Performance of Hitech Bio Pharmaceuticals.
Hitech Bio Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hitech Bio Pharmaceuticals?
Unlock access to Hitech Bio Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hitech Investigation And Intelligence Agency Private LimitedActive 4 years 11 monthsNeeraj Tiwari and Neelam Tiwari are mutual person
Hitech Human Capital Private LimitedActive 9 years 5 monthsNeeraj Tiwari and Neelam Tiwari are mutual person
Hitech Holiday Planners Private LimitedActive 1 year 11 monthsNeeraj Tiwari and Neelam Tiwari are mutual person
- Hitech Human Capital (India) LimitedActive 11 months 27 days
Neeraj Tiwari and Neelam Tiwari are mutual person
- Hitech Institute Of Security And Safety Management Private LimitedActive 3 years 8 months
Neeraj Tiwari and Neelam Tiwari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hitech Bio Pharmaceuticals?
Hitech Bio Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hitech Bio Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hitech Bio Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
